Optimal 2:1 EPA/DHA ratio in a highly bioavailable softgel
Provides 600 mg of EPA, 300 mg of DHA, and 100 mg of CoQ10 per softgel
Pharmaceutical-grade omega-3 blend, verified by the USP for quality and consistency
Free of lipid peroxides and environmental pollutants, including heavy metals, pesticides, dioxins, PCBs, and other harmful compounds.
Sourced from wild-caught anchovies, sardines, and/or mackerel, among nature's best sources of EPA and DHA.
Harvested using sustainable fishing practices This Highly potent combination of CoQ10 and omega-3 fatty acids EPA/DHA provides cardiovascular and cognitive benefits through multiple distinct and overlapping pathways. CoQ10 and EPA/DHA have been shown to improve endothelial function, particularly in populations at risk for atherosclerosis (high BMI, metabolic syndrome, smoking, hyperlipidemia), with clinically significant hypotensive and anti-atherogenic effects.
CoQ10 plays a critical role in oxidative phosphorylation and mitochondrial bioenergetics, which are essential for neuronal health and the prevention of mitochondrial dysfunction that underlies many chronic diseases, including neurodegenerative diseases. In addition, recent data highlight an emerging role for CoQ10 in reducing inflammation and insulin resistance, which are important contributors to impaired cognitive function. A meta-analysis of randomized trials showed that CoQ10 and EPA/DHA supplementation reduced key biomarkers of inflammation, including C-reactive protein, TNF-alpha, and IL-6. Serum CoQ10 levels have also been associated with neurological outcomes after ischemic stroke, as well as the risk of debilitating dementia. OptiMega-3 Q10 also provides high doses of pharmaceutical-grade EPA/DHA, which has been shown to reduce numerous cardiovascular risk factors and improve vascular function, with controlled clinical trials demonstrating a reduction in the rate of cardiovascular and coronary events, particularly in high-risk individuals. Omega-3 fatty acids have been linked to a reduction in myocardial infarction and stroke, with supplementation mitigating adverse left ventricular changes, myocardial fibrosis, and systemic inflammation after myocardial infarction. EPA/DHA supports cognitive function through multiple mechanisms, as both are essential for neuronal membranes, with lower levels being not only a marker of neurological disease but also a risk factor for cognitive impairment.
Provides 600 mg of EPA, 300 mg of DHA, and 100 mg of CoQ10 per softgel
Pharmaceutical-grade omega-3 blend, verified by the USP for quality and consistency
Free of lipid peroxides and environmental pollutants, including heavy metals, pesticides, dioxins, PCBs, and other harmful compounds.
Sourced from wild-caught anchovies, sardines, and/or mackerel, among nature's best sources of EPA and DHA.
Harvested using sustainable fishing practices This Highly potent combination of CoQ10 and omega-3 fatty acids EPA/DHA provides cardiovascular and cognitive benefits through multiple distinct and overlapping pathways. CoQ10 and EPA/DHA have been shown to improve endothelial function, particularly in populations at risk for atherosclerosis (high BMI, metabolic syndrome, smoking, hyperlipidemia), with clinically significant hypotensive and anti-atherogenic effects.
CoQ10 plays a critical role in oxidative phosphorylation and mitochondrial bioenergetics, which are essential for neuronal health and the prevention of mitochondrial dysfunction that underlies many chronic diseases, including neurodegenerative diseases. In addition, recent data highlight an emerging role for CoQ10 in reducing inflammation and insulin resistance, which are important contributors to impaired cognitive function. A meta-analysis of randomized trials showed that CoQ10 and EPA/DHA supplementation reduced key biomarkers of inflammation, including C-reactive protein, TNF-alpha, and IL-6. Serum CoQ10 levels have also been associated with neurological outcomes after ischemic stroke, as well as the risk of debilitating dementia. OptiMega-3 Q10 also provides high doses of pharmaceutical-grade EPA/DHA, which has been shown to reduce numerous cardiovascular risk factors and improve vascular function, with controlled clinical trials demonstrating a reduction in the rate of cardiovascular and coronary events, particularly in high-risk individuals. Omega-3 fatty acids have been linked to a reduction in myocardial infarction and stroke, with supplementation mitigating adverse left ventricular changes, myocardial fibrosis, and systemic inflammation after myocardial infarction. EPA/DHA supports cognitive function through multiple mechanisms, as both are essential for neuronal membranes, with lower levels being not only a marker of neurological disease but also a risk factor for cognitive impairment.
Adults: 1 capsule 3 times daily or as directed by a healthcare practitioner.
Medicinal Ingredients: Fish Oil Concentrate (Molecularly Distilled, Ultra-Purified) (Anchovy, Sardine, and/or Mackerel) 1407 mg Omega-3 Fatty Acids 900 mg Eicosapentaenoic Acid (EPA) 600 mg Docosahexaenoic Acid (DHA) 300 mg Coenzyme Q10 (Microorganism) 100 mg Non-Medicinal Ingredients: Enteripure® Softgel (Gelatin, Glycerin, Purified Water, Pectin), Natural Vitamin E.
